A prospective study of clopidogrel therapy in dogs with primary immune-mediated hemolytic anemia.

@article{Mellett2011APS,
  title={A prospective study of clopidogrel therapy in dogs with primary immune-mediated hemolytic anemia.},
  author={Amelia M Mellett and Reid K Nakamura and Domenico Bianco},
  journal={Journal of veterinary internal medicine},
  year={2011},
  volume={25 1},
  pages={71-5}
}
BACKGROUND A major cause of death in dogs with primary immune-mediated hemolytic anemia (pIMHA) is thrombotic disease. Ultralow-dose aspirin (ULDA) is commonly used to prevent thrombosis in dogs with pIMHA; however, the efficacy of antiplatelet agents in dogs with pIMHA is unknown. HYPOTHESIS The use of clopidogrel (CL), alone or in combination with ULDA, would improve survival to discharge and at 90 days without important adverse effects compared with ULDA alone in dogs with pIMHA treated… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
16 Extracted Citations
29 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 16 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 29 references

Clopidogrel therapy in dogs with immune - mediated hemolytic anemia

  • RL dHaviland, N Pacifico, D Bianco
  • J Vet Intern Med
  • 2009

Comparison of individually monitored versus low - dose aspirin on survival of dogs with immune - mediated hemolytic anemia

  • ES Orcutt, DJ Polzin, PJ Armstrong
  • J Vet Intern Med
  • 2009

Effects of aspirin and clopidogrel on platelet function in healthy dogs

  • L Shearer, SA Kruth, D Wood
  • J Vet InternMed
  • 2009

Veterinary Hematology: Atlas of Common Domestic and Non-Domestic Species

  • ReaganWJ, AR IrizarryRovira, DB DeNicola
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…